Healthy Skepticism Library item: 13224

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Marketing influences antidepressant prescriptions: study
ABC News 2008 Mar 18
http://www.abc.net.au/news/stories/2008/03/18/2192129.htm

Full text:

New research into marketing by pharmaceutical companies has found that
doctors and psychiatrists are being influenced by the branding of
antidepressant drugs.

Dr Steven Ward from Perth’s Murdoch University will publish research
later this year which compares the chemical ingredients of
antidepressants and the marketing of them to health professionals.

The research has found drugs which are well branded and marketed to
health professionals are more commonly prescribed than similar, less
marketed alternatives.

Dr Ward says GPs also rate drug company representatives as their second
most important source of information on pharmaceuticals.

“We relied on looking at, was brand name that important or was it the
actual drug, or the chemical differences in the drug that were the
driving factor? We find that they’re equally important,” he said.

“That’s very surprising, regardless of medical training, I expected it
to be less important, particularly for psychiatrists.”

He says the pharmaceutical industry spends $21,000 per Australian doctor
each year marketing and branding drugs.

“With for example financial planners, there is a requirement to disclose
any gifts, inducements etc,” he said.

“Here we have a group of people who are making important decisions and
if there are any inducements and so on, there may be a role for some
sort of transparency in that process.”

Australian Medical Association president, Rosanna Capolingua, has
rejected the findings saying doctors prescribe the medication they
believe will benefit the patient most.

“Often when a new drug is launched, information is distributed,” she said.

“You may see doctors using that new drug on a patient because it has new
benefits.

“It may have better qualities than other medications and you’ll see that
trend occur.”